NASDAQ:IART
Integra LifeSciences Holdings Corp Stock News
$29.17
-0.0700 (-0.239%)
At Close: Apr 30, 2024
Integra's Update On FY21 Acell Revenues To Weigh On Stock, Piper Sandler Says
02:29pm, Wednesday, 28'th Jul 2021
Piper Sandler has raised the price target on Integra LifeSciences Holding Corporation (NASDAQ:IART) to $72 from $70 and reiterated a Neutral rating following the Q2 beat. The company posted Q2
Integra LifeSciences (IART) Tops Q2 Earnings and Revenue Estimates
08:23am, Wednesday, 28'th Jul 2021
Integra (IART) delivered earnings and revenue surprises of 17.91% and 3.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Integra Lifesciences Q2 Earnings
07:14am, Wednesday, 28'th Jul 2021
Shares of Integra Lifesciences (NASDAQ:IART) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 139.39% over the past year to $0.79, which beat the es
Integra LifeSciences Reports Second Quarter 2021 Financial Results
06:00am, Wednesday, 28'th Jul 2021
Raises Full-Year 2021 Guidance Raises Full-Year 2021 Guidance
Medical Device Stocks' Earnings on Jul 28: TMO, ALGN & More
12:15pm, Tuesday, 27'th Jul 2021
The sector's Q2 results are likely to reflect solid earnings and revenue growth on strong base business recovery.
Integra (IART) Releases Favorable PriMatrix Clinical Outcome
08:29am, Tuesday, 20'th Jul 2021
Integra's (IART) PriMatrix study data validates that one application of PriMatrix is needed to address hard-to-heal diabetic foot ulcers.
Data Shows a Single Application of PriMatrix Closed More Wounds Than Standard of Care Alone Data Shows a Single Application of PriMatrix Closed More Wounds Than Standard of Care Alone
Integra's (IART) SurgiMend Gets Innovative Technology Contract
10:04am, Thursday, 15'th Jul 2021
Integra's (IART) SurgiMend Collagen Matrix is recognized as a product that can potentially bring improvement to the health care industry.
Integra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend® Collagen Matrix for Soft Tissue Reconstruction
04:30pm, Wednesday, 14'th Jul 2021
Contract awarded for products that bring improvement to healthcare industry Contract awarded for products that bring improvement to healthcare industry
Integra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021
08:30am, Thursday, 08'th Jul 2021
PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2021 financial res
Integra LifeSciences Announces CEO Succession Plan
08:30am, Thursday, 24'th Jun 2021
Peter Arduini to serve as President and CEO through the end of 2021 Candidate search launched to identify successor Peter Arduini to serve as President and CEO through the end of 2021 Candidate search
Integra (IART) Tissue Technologies Rebounds Amid Supply Woe
10:31am, Tuesday, 01'st Jun 2021
Integra's (IART) CSS segment too reflects a gradual recovery in procedure-based market as well as an improvement in hospital capital spending during the first quarter.
Integra LifeSciences Hosts Virtual Investor Day
06:00am, Thursday, 20'th May 2021
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m
Integra LifeSciences to Host Virtual Investor Day on May 20, 2021
08:30am, Friday, 07'th May 2021
PRINCETON, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q1 2021 Results - Earnings Call Transcript
11:09pm, Wednesday, 28'th Apr 2021
Integra LifeSciences Holdings Corporation (IART) CEO Peter Arduini on Q1 2021 Results - Earnings Call Transcript
